We note that a Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) insider, Anil Gupta, recently sold ₹956k worth of stock for ₹239 per share. However we note that the sale only shrunk their holding by 2.8%.
See our latest analysis for Advanced Enzyme Technologies
The Last 12 Months Of Insider Transactions At Advanced Enzyme Technologies
The Director of Operations & Whole Time Director Mukund Kabra made the biggest insider purchase in the last 12 months. That single transaction was for ₹13m worth of shares at a price of ₹99.00 each. We do like to see buying, but this purchase was made at well below the current price of ₹234. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.
Over the last year, we can see that insiders have bought 564.26k shares worth ₹64m. On the other hand they divested 4.00k shares, for ₹956k. In the last twelve months there was more buying than selling by Advanced Enzyme Technologies insiders. Their average price was about ₹114. To my mind it is good that insiders have invested their own money in the company. But we must note that the investments were made at well below today's share price. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!
There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).
Insider Ownership of Advanced Enzyme Technologies
For a common shareholder, it is worth checking how many shares are held by company insiders. We usually like to see fairly high levels of insider ownership. Advanced Enzyme Technologies insiders own about ₹12b worth of shares (which is 48% of the company). Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.
So What Does This Data Suggest About Advanced Enzyme Technologies Insiders?
An insider hasn't bought Advanced Enzyme Technologies stock in the last three months, but there was some selling. In contrast, they appear keener if you look at the last twelve months. And insider ownership remains quite considerable. So we're not too bothered by recent selling. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. You'd be interested to know, that we found 2 warning signs for Advanced Enzyme Technologies and we suggest you have a look.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Promoted
If you decide to trade Advanced Enzyme Technologies, use the lowest-cost* platform that is rated #1 Overall by Barron’s, Interactive Brokers. Trade stocks, options, futures, forex, bonds and funds on 135 markets, all from a single integrated account.
This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.